Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
National blood stocks have fallen by 7% over the jubilee weekend according to latest figures from NHS Blood and Transplant (NHSBT) which today launches its annual awareness campaign, National Blood Week, to urge the public to donate blood.
During the National Blood Week recruitment drive additional appointments have been created and selected blood donor sessions have extended opening hours to give donors more flexibility to schedule a visit. Regional recruitment events will also be driving awareness and enabling people to sign up.
To launch the 2012 National Blood Week, Made In Chelsea’s Rosie Fortescue has rolled her sleeves up to recreate the heroic ‘Rosie the Riveter’ WWII poster and issue a rallying cry for new and existing blood donors to come forward. Rosie Fortescue, who shares her name with the 1940s poster girl, said: “This woman clearly knew how to get things done, and I feel honoured to become a modern day campaigner for the national blood stock build. Blood supplies are vital to the health service and every unit of blood can save or improve the lives of up to three people.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/56548-nhs-blood-transplant
New research debuted at the American Diabetes Association’s 72nd Annual Scientific Session suggests eating raisins three times a day may significantly lower postprandial (post-meal) glucose levels when compared to common alternative snacks of equal caloric value. The study was conducted at the Louisville Metabolic and Atherosclerosis Center (L-MARC) by lead researcher, Harold Bays, MD, medical director and president of L-MARC.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56845-california-raisin-marketing-board-raisins-reduce-post-meal-blood-sugar
Roche announced today the U.S. introduction of the cobas b 123 POC system, a mobile blood gas analyzer designed for hospital point of care settings. The system’s next-generation technology helps ensure reliable performance by virtually eliminating the introduction of blood clots that can contribute to analyzer downtime and negatively impact patient care.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57116-roche-cobas-b-123-poc-system-mobile-blood-gas-analyzer-hospital-technology
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor. This new approach to treating blood cancers works by blocking BTK, a protein that helps certain cancer cells live and grow.1 IMBRUVICA is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy, or in first line in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762540-janssen-ec-approval-imbruvica-mcl-cll/
HOME BLOOD PRESSURE MONITORS: https://amzn.to/2Yers09
THE HIGH BLOOD PRESSURE PROGRAM: https://bit.ly/2HR7gvw
BLOOD PRESSURE SUPPORT FORMULA:http://www.lnk123.com/SHwJN
High blood pressure during pregnancy can lead to serious, life threatening health issues for you or your baby. Watch this video which will tell you how to lower your blood pressure during pregnancy, your health depends on it!
It is dark, dirty and twisted. This is a vampire show with real bite, and here it kicks some ass. Catch the UK premiere, Fridays at 10pm from July 17th exclusively on FX.
Zev is an elite hunter, fierce and lethal. But when Branislava wakens him in a warrior’s cave where he was put for his own protection, Zev feels a new awakening in more ways than he could have ever imagined. Vampires and rogue Lycans are not all Zev and Branaslava will have to fight if they are to survive. A mysterious evil lurks nearby. One that not even the Carpathians can see coming. One that may cost them all dearly. Find out more at http://www.ChristineFeehan.com. Paranormal Romance
There is a lot of controversy and debate about whether you need to do a colon cleansing. Some say it is necessary and others say it's a waste of money and can do your body harm. You can imagine who it says it harms. Doctors say it's a waste of time and practitioners that offer a colon cleansing service cleansing say it is not. So who will you believe?
